Rinkey Investments’s BioAtla BCAB Stock Holding History

Rinkey Investments’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-506	Closed	-$44.5K	–	91
2024 Q3	$44.5K	Hold	506	–	–	0.01%	79
2024 Q2	$34.7K	Buy	+506	New	+$60.2K	0.01%	69
2024 Q1	–	Sell	-506	Closed	-$62.3K	–	72
2023 Q4	$62.3K	Buy	+506	New	+$43.9K	0.02%	58
2023 Q3	–	Sell	-506	Closed	-$75.9K	–	49
2023 Q2	$75.9K	Buy	506 +2	+0.4%	+$344	0.03%	57
2023 Q1	$67.6K	Hold	504	–	–	0.04%	53
2022 Q4	$208K	Hold	504	–	–	0.12%	47
2022 Q3	$226K	Buy	504 +36	+8%	+$11.8K	0.17%	32
2022 Q2	$76K	Buy	+468	New	+$74.5K	0.07%	42
2022 Q1	–	Hold	0	–	–	–	62
2021 Q4	–	Hold	0	–	–	–	256

Other funds holding BCAB

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Rinkey Investments's BCAB Position: Q4 2024 in Review

Rinkey Investments sold out of BioAtla (BCAB) in Q4 2024, closing a stake of 506 shares — an estimated $44.5K sold.

Rinkey Investments first reported a position in BCAB in Q2 2022 and held it in 8 quarters. The position peaked at $226K in Q3 2022. 67 funds tracked by Wall St. Rank hold BCAB as of Q4 2024.

Rinkey Investments reported no remaining BioAtla position as of Q4 2024 after selling out during the quarter.
Rinkey Investments sold 506 BioAtla shares in Q4 2024, an estimated $44.5K.
Rinkey Investments first reported a position in BioAtla in Q2 2022 and held it in 8 quarters.
Rinkey Investments's BioAtla position peaked at $226K in Q3 2022.
67 funds tracked by Wall St. Rank held BioAtla as of Q4 2024.

Based on Rinkey Investments's 13F filing for Q4 2024, filed 14 Feb 2025.